Credent Connect N Care’s IPO witnessed strong interest from investors, achieving 2.18 times subscription on its opening day, August 13. Retail investors led the demand with a 3.11 times subscription. The healthcare logistics firm aims to raise ₹93.90 crore through this issue to fund working capital, machinery, and debt repayment.
Credent Connect N Care opened its initial public offering (IPO) on August 13, 2026, receiving a positive response from the market. By the end of the first day, the public issue was subscribed 2.18 times, indicating solid interest from potential shareholders. The total offer size consists of 49.68 lakh shares.
Retail investors were the most active, subscribing 3.11 times their allocated portion. Meanwhile, the quota for Non-Institutional Investors (NII) was subscribed 1.59 times, and the portion reserved for Qualified Institutional Buyers (QIB) was fully subscribed at 1.00 time. The IPO will remain open for bidding until August 17.
The company is offering shares in the price band of ₹179 to ₹189, with a minimum lot size of 600 shares for retail bidders. Credent Connect N Care is a healthcare logistics provider. The company’s growth prospects have gained attention partly due to the presence of prominent market figures like Ashish Kacholia and Sunil Singhania’s Abakkus Asset Manager among its backers.
Regarding the use of funds, the company plans to utilize the ₹93.90 crore raised from the fresh issue for several purposes. A portion of the proceeds is earmarked for working capital requirements at its subsidiary, Credent Healthcare, while other funds will go toward machinery expansion and debt repayment. General corporate purposes will also be supported by the remaining capital.
Investors considering this IPO should note the risks associated with the healthcare logistics sector. The company's operations are highly sensitive to timing and precision, as it deals with the transport of diagnostic samples. Any failure in this service could impact the company's reputation and financial health. Furthermore, the business is working capital intensive, meaning any delay in receiving payments could strain liquidity. The company also faces customer concentration risk, as it relies on a limited number of major clients, and the loss of any key contract could materially affect revenue.
Additionally, the company depends on a geographically spread-out and skilled workforce, and the inability to retain or manage this talent effectively could pose an operational challenge. As the company uses the new capital for expansion, maintaining profit margins amid competitive pressure will be an important factor for long-term performance. The shares are proposed to list on the NSE SME platform on August 20, 2026. The lead manager for the issue is Hem Securities Limited, and the registrar is Kfin Technologies Limited.